Acclarent, Inc. Completes Office-Based Study Using Balloon Sinuplasty(TM) Technology
“We are very pleased to have completed this study demonstrating that physicians can successfully treat patients in the office setting using our enabling technology,” said
Acclarent is a global medical technology company dedicated to the development of innovative products to further meet the needs of ENT surgeons and their patients.
Acclarent’s initial focus is on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools – Balloon Sinuplasty(TM) devices. With the Balloon Sinuplasty(TM) technology and our Relieva(R) product portfolio we offer ENT patients alternatives to conventional endoscopic surgical approaches. Through our core technologies and commitment to innovation, Acclarent will continue to advance novel technologies in all areas of ENT. Acclarent markets and sells its products worldwide and our technology has been used by thousands of physicians.
For more information about Acclarent, visit www.Acclarent.com.
SOURCE Acclarent, Inc.